AMAG Pharmaceuticals publicly offering 3 million shares of common stock

AMAG Pharmaceuticals offering 3 million shares

LEXINGTON, Mass. — AMAG Pharmaceuticals Inc. said Wednesday it is publicly offering 3 million shares of common stock.

The biotechnology company is also granting underwriters an overallotment option for 450,000 shares. Morgan Stanley & Co., J.P. Morgan Securities Inc., and Goldman Sachs & Co. are underwriting the offering.

The company has not priced the offering. In a regulatory filing, AMAG Pharmaceuticals said it plans to use proceeds for general corporate purposes including research and development.

AMAG has about 17.1 million common shares outstanding.

Shares of AMAG closed at $49.99 Tuesday. The stock has traded in a 52-week range of $22.20 to $58.23.